Anti-Osteoporotic Actions of Estrogens

Kirkwood, Keith L.

Abstract

The inositol trisphosphate receptor (IP3R) is an intracellular calcium channel that mediates the cellular actions of many hormones, growth factors, and cytokines. In osteoblastic cell cultures, many bone resorbing hormones increase inositol trisphosphate production, mobilization of intracellular calcium, and secretion of osteoclast recruitment and activating factors. The effects of 17B-estradiol, 1,25-dihydroxyvitamin D3, phorbol esters and serum on IP3R mRNA levels were evaluated in osteogenic-osteosarcoma cells (G-292, U-2 OS, Saos-2, MC3T3-El and UMR-106) and in primary osteoblastic cultures derived from neonatal rat calvaria. Type specific RT-PCR indicated that all cell types evaluated express IP3R mRNA type I; G-292, U-2 OS, MC3T3-El, and calvarial osteoblastic cells express type II IP3R mRNA; and UMR-106 and the calvarial osteoblastic cells express type III IP3R gene. Northern blot analysis indicated that phorbol ester and serum increase steady state IP3R mRNA expression in G-292 cells and in calvarial osteoblastic cells. Further characterization of IP3R gene expression in G-292 cells indicated that 17B-estradiol and 1,25-dihydroxyvitamin D3 decrease IP3R mRNA levels. The effect of 17B-estradiol was not due to accelerated IP3R mRNA degradation and required continued protein synthesis. The results indicate that IP3R expression in osteoblastic osteosarcoma cells is affected by 17B-estradiol and other osteoporotic and anti-osteoporotic hormones and may be important in the chronic regulation of osteoblast secretory activity.

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Dental & Craniofacial Research (NIDCR)
• Type: Unknown (K16)
• Project #: 2K16DE000158-11
• Application #: 5210015
• Support Year: 11
• Fiscal Year: 1996

Publications

Krebs, Linda J; Wang, Xiaopeng; Nagy, Atilla et al. (2002) Bombesin and epidermal growth factor potentiate the effect of cytotoxic LH-RH analog AN-152 in vitro. Int J Oncol 21:1325-9

Krebs, Linda J; Wang, Xiaopeng; Nagy, Attila et al. (2002) A conjugate of doxorubicin and an analog of Luteinizing Hormone-Releasing Hormone shows increased efficacy against oral and laryngeal cancers. Oral Oncol 38:657-663

Rogers, J D; Scannapieco, F A (2001) RegG, a CcpA homolog, participates in regulation of amylase-binding protein A gene (abpA) expression in Streptococcus gordonii. J Bacteriol 183:3521-5

Krebs, L J; Wang, X; Pudavar, H E et al. (2000) Regulation of targeted chemotherapy with cytotoxic lutenizing hormone-releasing hormone analogue by epidermal growth factor. Cancer Res 60:4194-9

Malek, R; Fisher, J G; Caleca, A et al. (1994) Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats. J Bacteriol 176:1052-9

Dolce, C; Anguita, J; Brinkley, L et al. (1994) Effects of sialoadenectomy and exogenous EGF on molar drift and orthodontic tooth movement in rats. Am J Physiol 266:E731-8

Stephan, E B; Dziak, R (1994) Effects of genistein, tyrphostin, and pertussis toxin on EGF-induced mitogenesis in primary culture and clonal osteoblastic cells. Calcif Tissue Int 54:409-13

Grossi, S G; Zambon, J J; Ho, A W et al. (1994) Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 65:260-7

Winston, J L; Chen, C K; Neiders, M E et al. (1993) Membrane protein expression by Actinobacillus actinomycetemcomitans in response to iron availability. J Dent Res 72:1366-73

Sharma, A; Sojar, H T; Lee, J Y et al. (1993) Expression of a functional Porphyromonas gingivalis fimbrillin polypeptide in Escherichia coli: purification, physicochemical and immunochemical characterization, and binding characteristics. Infect Immun 61:3570-3